HTB homepage • Conference reports • Articles by subject • Subscribe August 2008 Contents Editorial Volume 9 Number 7/8 Jul/Aug 2008 Conference reports XVII International HIV Resistance Workshop (IHDRW), 6-10 June 2008, Sitges Integrase inhibitor resistance and cross-resistance: weighing viral fitness and the option to benefit from second-generation compounds Understanding etravirine susceptibility: new weighted genotype score and phenotypic cut-offs Pipeline antiretrovirals: IDX899, CHX157 and bevirimat Lack of virological impact of treatment intensification in suppressed patients supports latent viral reservoir as source of residual viraemia NNRTI resistance in infants prophylaxed with single-dose nevirapine varies by the timing of infection Detecting viral tropism: impact of a more sensitive Trofile (ES) assay Low frequency K103N mutations are associated with poor virological response to NNRTI based therapy 14th Annual BHIVA Conference, 23-25 April 2008, Belfast Bone problems raised in several UK studies Late diagnosis in adolescence of vertically acquired HIV infection Case study of multi-drug resistant woman receiving newer antiretroviral drugs in pregnancy Predictors of treatment failure in Western Cape, South Africa Late pregnancy loss in HIV-positive women Renal tubular dysfunction with tenofovir-based HAART in four vertically infected adolescents 15th Conference on Retroviruses and Opportunistic Infections, Boston, 2-6 February 2008 The unmet need for contraception services for women receiving ART Valacyclovir decreases plasma and genital viral loads in HSV-2/HIV-1 co-infected women HPV genotypes in HIV-positive women in Zimbabwe and Uganda Antiretrovirals Boosted atazanavir approved in Europe as first-line therapy BMS and Merck discontinue 100mg capsule formulation of efavirenz used for paediatric treatment Saquinavir (Invirase) interactions with digoxin, garlic capsules, methadone, tipranavir and omeprazole: US label changes US label changes for nevirapine paediatric solution New US pediatric dosing for lopinavir/r New US pediatric dosing for tipranavir/r DSMB stops ACTG study due to suboptimal responses Treatment access FDA approval of generic ARVs Access to generic efavirenz in South Africa: MSD agrees to grant licenses on reasonable terms Reaching 3 by 5…by 7: new report on universal access Oxfam criticises DFID’s new strategy as a “missed opportunity” Pregnancy Low rates of MTCT in UK and Ireland Paediatric care WHO recommends treating all HIV-infected infants aged less than 12 months Plasma concentrations and virologic evaluations after stopping NNRTI treatment in PENTA 11 Guidelines UK (BHIVA) 2008 Treatment Guidelines published online Major updates to US guidelines on prevention and treatment of OIs (2008) Basic science and immunology Elite control of a virus that caused AIDS in the transmitting partner Presentations from the May 21-23 HIV Vaccine Trials Network (HVTN) Meeting Failure of STEP leads TAG to criticise the proposed PAVE100A vaccine trial Other news Free osteopathy for people with HIV at the British School of Osteopathy AIDS denialists shut out of Senate hearing after winning “whistleblower” award MTV internet game challenges ignorance and assumptions about who has HIV On the web PRN notebook JACI special issue on prospects for eradication New resources from HIV InSite Overview of mucosal transmission PDFs Volume 9 Number 7/8 Jul/Aug 2008 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
